Clinical Trial Update: Cannabidiol for Reducing Cigarette Use [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating cannabidiol to reduce cigarette use in adults with tobacco use disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Dependence
• Tobacco Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Tobacco Use Disorder, Tobacco Smoking | Phase 2 | Status: RECRUITING